LoginSignup
Arena Pharma logo

Arena Pharma

Stock
Stock
ISIN: US0400476075
Ticker: ARNAn
US0400476075
ARNAn

Price

Price

Frequently asked questions

What is Arena Pharma's market capitalization?

The market capitalization of Arena Pharma is $6.17B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Arena Pharma?

Arena Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$10.13. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Arena Pharma's stock?

Currently, 8 analysts cover Arena Pharma's stock, with a consensus target price of $97.86. Analyst ratings provide insights into the stock's expected performance.

What is Arena Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Arena Pharma reported a revenue of $54.00K.

What is the EBITDA for Arena Pharma?

Arena Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$541.79M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Arena Pharma?

Arena Pharma has a free cash flow of -$523.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Arena Pharma's stock?

The 5-year beta for Arena Pharma is 0.53. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Arena Pharma have, and what sector and industry does it belong to?

Arena Pharma employs approximately 448 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Arena Pharma's shares?

The free float of Arena Pharma is 61.03M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $6.17B

5Y beta

 0.53

EPS (TTM)

 -$10.13

Free Float

 61.03M

Revenue (TTM)

 $54.00K

EBITDA (TTM)

 -$541.79M

Free Cashflow (TTM)

 -$523.00M

Analyst Ratings

The price target is $97.86 and the stock is covered by 8 analysts.

Buy

2

Hold

6

Sell

0

Information

Arena Pharmaceuticals Inc is a United States-based clinical stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of several immuno-inflammatory diseases. It delivers transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. The Company's clinical programs include Etrasimod, which is an oral, selective sphingosine 1-phosphate (S1P), receptor modulator, designed to provide systemic and local cell modulation by targeting S1P receptor subtypes one, four and five.

448

Biotechnology & Drugs

Health Care

Identifier

ISIN

US0400476075

Primary Ticker

ARNAn
Join the conversation
Sign upLogin